Tenderfy

Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

Comprador
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
Publicado
2026-11-16
Plazo
2026-12-16T13:00:00+00:00
Fuentes
UK_FTS
Valor
270000.0 GBP

Descripción

La descripción está en el idioma de la fuente.

The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response. We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory’s existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.

CPV: 38950000

Suscripción

Consulte gratis el resumen de cada anuncio. Los enlaces al anuncio oficial y sus documentos, los permisos de construcción y el acceso MCP personal requieren una suscripción de pago activa.

Leer